Podcasts about annual meetings

Send us Fan MailJoin Chris Hardesty, MD, as she chats with Andrew K. Cree, MD, and Brian Hsu, MD—two of our “local hosts” for the upcoming SRS Annual Meeting in Sydney, Australia! Tune in for their insider tips on the best things to do beyond the meeting, including must-visit cafés and restaurants, local activities, and Sydney sights you won't want to miss.Check out the guide that Dr. Cree put together for more! 

This month, we have Public and Member Relations Coordinator Amanda Busby to tell you all about Annual Meeting.

This podcast brings the data behind the poster (which can be found on the MAPS Knowledge Center: https://medicalaffairs.org/knowledge-center/) to life, exploring insights from a double-blind survey of 10,000+ healthcare professionals on how Medical Information is delivered by the Top 10 global pharma companies. It highlights that two out of three HCPs find Medical Information relevant and that it contributes approximately 15% to perceptions of Medical Affairs leadership, while discussing what differentiates top performers and how Medical Information can be leveraged more strategically. Learning Objectives - What you'll learn in this Episode:- How healthcare professionals perceive Medical Information across top global pharma companies- Why Medical Information contributes meaningfully to leadership credibility in Medical Affairs- What top‑performing organizations do differently to build trust, relevance, and differentiation- How HCP feedback can be translated into actionable Medical Information strategyFaculty:Brad Tritle, GM and Medical Affairs Sales Lead, Americas, TrilationsLINKEDIN: https://www.linkedin.com/in/bradtritle/ Leen Helsloot, Medical Affairs Practice Lead, TrilationsLINKEDIN: https://www.linkedin.com/in/leen-helsloot-84a34b4/ Dhara Patel, Director, Medical Information, Siemens HealthineersLINKEDIN: https://www.linkedin.com/in/dhara-patel-pharmdd-65bba4216/About the Medical Affairs Professional Society (MAPS) The Medical Affairs Professional Society (MAPS) is the leading global authority and community for Medical Affairs professionals, uniting over 18,000 members across 400+ organizations in Pharmaceutical, Biotech, MedTech, and related industries. Founded in 2016, MAPS is a 501(c)(3) nonprofit dedicated to advancing careers and elevating the Medical Affairs profession worldwide.  

Radio Free 501c brought to you by Rogue Tulips Consulting and USAE News!Episode 343: Strategic AlliancesHost: Cecilia Sepp, CAE, ACNP, LPEC, Principal, Rogue Tulips ConsultingGuest: Paula Seidel, CAE, IOM, Founder, Powerful PartnersMy guest Paula brings her expertise in relationship management to the broader conversation of alliances and partnerships. Inspired by her recent presentation at ASAE's 2026 Annual Meeting, we dive into what makes relationships work, why we should collaborate more often, and the fact that we can do more together than alone. Our conversation highlights:Defining Strategic Alliances vs. Partnership​sIdentifying Alliance OpportunitiesConducting Due DiligenceResource and Outcome SharingFocusing on the Human ElementPaula is a fresh voice in the association world and her passion and commitment shine through! If you want to improve your organization's relationships then this is the episode for you. What would you like to improve about your strategic alliances? Share a comment! 

Chuck and Chris host a live podcast at the ASSH Annual Meeting in Boston.  Special guest Greg Merrell discusses new initiatives at the Journal of Hand Surgery to kick things off.  We discussed meeting highlights with audience members, hit on several controversies, reviewed the Touch Prosthesis for CMC, and so much more!  We apologize for the audio quality being subpar.See www.practicelink.com/theupperhand for more information from our partner on job search and career opportunities.The Upper Hand Podcast is sponsored by Checkpoint Surgical, a provider of innovative solutions for peripheral serve surgery. To learn more, visit https://checkpointsurgical.com/.As always, thanks to @iampetermartin for the amazing introduction and concluding music.For additional links, the catalog.  Please see https://www.ortho.wustl.edu/content/Podcast-Listings/8280/The-Upper-Hand-Podcast.aspx

Featuring perspectives from Dr Brad S Kahl, Dr Jeff Sharman and Dr Tanya Siddiqi, including the following topics: Introduction (0:00) Trials in Progress (1:12) Chronic Lymphocytic Leukemia (7:09) Diffuse Large B-Cell Lymphoma (32:35) Mantle Cell Lymphoma (58:25) Follicular Lymphoma (1:14:49) CME information and select publications

Featuring perspectives from Dr Joyce F Liu, Dr David M O'Malley and Dr Brian M Slomovitz, moderated by Dr O'Malley, including the following topic: Case: A woman in her late 50s with a BRCA1 germline mutation and platinum- and PARP inhibitor-resistant metastatic ovarian cancer with low folate receptor alpha level and HER2 IHC 1+ — Professor Jonathan A Ledermann CME information and select publications

Send us Fan MailGet ready for the 2026 Annual Meeting and revisit the 2025 Harrington Lecture: Where are We Going? What are We Doing? Just Keep Asking! If you are attending the 2026 Annual Meeting, the 2026 Harrington Lecture is Thursday, October 8 on the topic The View from the Second Mountain: Transitions in Deformity, Career, and Life by Todd J. Albert, MD.*The Scoliosis Research Society (SRS) podcast is aimed at delivering the most current and trusted information to clinicians that care for patients with scoliosis and other spinal conditions. From news in the world of spinal conditions, to discussions with thought leaders in the field, we aim to provide up-to-date, quality information that will impact the daily practice of spinal conditions.

This week at NSTA: The Bus Stop- Executive Director Curt Macysyn welcomes first-time guest Denise Patocka, National Account Manager at REI and NSTA Vendor Partner, as part of NSTA's Back-to-School Series. Denise begins by sharing her professional journey and the experiences that led her to the student transportation industry. Curt and Denise discuss how REI approaches innovation with student safety as its primary focus and explore the critical role technology plays in helping transportation departments protect students and support operations. Looking ahead, the duo discuss the opportunities and challenges organizations face during the busy back-to-school season, as well as the importance of collaboration between vendors and operators when implementing new technologies. Curt and Denise also highlight the value of industry engagement through live events like NSTA's Annual Meeting and Convention, where the industry can connect, learn, and share best practices. The episode wraps up with Denise sharing a favorite back-to-school memory and information on how listeners can learn more about REI and its commitment to advancing safety and technology in student transportation. Become a podcast subscriber and don't miss an episode of NSTA: The Bus Stop - NSTA Vendor Partners should reach out to us to take advantage of our comprehensive advertising package that reaches your target audience - student transportation professionals!Support the show

Season 40: America's 250th Anniversary -- 50 states, 25 double-feature episodes. This is Episode 13, coveringRhode Island and North Dakota with two true crime cases from the 1880s and 1890s that circle the samequestion: who do you believe when the dead cannot speak?October 1885. A wealthy Black businessman in Newport, Rhode Island, is found dead at his kitchen table -- twogunshot wounds, unchewed bread still in his mouth. The city calls it suicide before the day is over. Eight yearslater, a hired hand in North Dakota murders six members of the family that trusted him, and a fifteen-year-oldgirl walks barefoot to town to report it.Both killers were inside the circle. Both were trusted. Both destroyed the people who let them in. This episodeexamines what trust costs in a country still deciding which lives deserve investigation and which can be dismissedwith a shrug from the mayor's office.The VictimsBenjamin J. Burton was the wealthiest Black businessman in Rhode Island when he was killed in October 1885.He had arrived in Newport around 1845 from Connecticut and spent four decades building a baggage transferempire -- the Original Express and the Bellevue Avenue Express Line -- moving trunks between the wharvesand the Gilded Age mansions. Burton was a civil rights organizer who helped desegregate Rhode Island's publicschools in 1866, working alongside Isaac Rice and George T. Downing. He was fifty-nine years old. He had beeneating breakfast when he was shot.Daniel and Barbara Kreider were a Mennonite farming family who had relocated from Lancaster County, Penn-sylvania, to a homestead southeast of Cando, North Dakota. Daniel was born in 1856; Barbara came from oneof Lancaster County's most established Mennonite families -- the Rissers, whose meeting house had been incontinuous operation since the 1700s. By summer 1893, they had eight children. Four of those children -- Bernice,thirteen; Murbey, eleven; Mary, nine; and David, seven -- were killed alongside their parents on the morning ofJuly 7, 1893.The CrimesIn Newport, Burton's son-in-law Allen Dorsey -- a medical student at the University of Pennsylvania, one year fromfinishing his degree -- shot Burton at 63 Levin Street on October 6, 1885. The wound sequence was medicallydamning: a shot to the head first, a shot to the heart second. No powder burns. Unchewed bread in the victim'smouth. The city ruled it suicide anyway. The coroner signed off. The mayor ridiculed the idea of murder.In North Dakota, Albert Bomberger -- a twenty-two-year-old hired hand who had lived with the Kreider family forfive years -- killed six family members with a shotgun in thirty minutes after the eldest daughter, Annie, rejectedhis advances and her father told him to leave. After the killings, Bomberger forced fifteen-year-old Annie to cookhis breakfast while the bodies lay in the rooms around her. He ate, ransacked the house, beat Annie with a rope,and fled toward Canada on a stolen pony.The InvestigationIn the Burton case, Newport's official investigation went nowhere. The community Burton had spent forty yearsbuilding ran a parallel investigation through church and civic networks. Seven weeks later, Burton's youngerdaughter Emmie came forward and named Allen Dorsey as the killer and Maria Dorsey as complicit. Her testimonymade prosecution possible. The trial began in late June 1886. Allen and Maria Dorsey were convicted andsentenced to life. Emmie was also convicted -- she had served as lookout -- and died of consumption in the prisoninfirmary within six months. In June 1887, the Burton case was presented to the American Medical Associationat their 38th Annual Meeting as an example of physical evidence clearly indicating murder that official authoritychose to read otherwise.Annie Kreider walked to Cando barefoot. No shoes, no horse, no telephone. Her testimony was the entirefoundation of the prosecution. Bomberger was captured at Deloraine, Manitoba, three days later. The threat oflynching was immediate -- the Grand Forks County sheriff moved Bomberger to a more secure jail. On November21, 1893, Bomberger was arraigned. Two days later, he was sentenced to death. The entire court proceedinglasted fifteen minutes. He was hanged on January 19, 1894 -- the first legal execution in North Dakota history.Historical ContextThese two historical murder cases sit at the edges of American justice in the Gilded Age. In Rhode Island, thesystem initially failed a Black man whose physical evidence was dismissed by the same city he had served fordecades. In North Dakota, a state just four years old produced a fifteen-minute guilty plea and a death sentencein two days -- justice delivered under the shadow of a lynch mob. Allen Dorsey was pardoned in 1912, moved toNew York City, worked as a waiter, and died in 1918. Annie Kreider lived until 1960, carrying that July morning forsixty-seven years.Our Sponsors:* Check out Kensington Publishing: https://www.kensingtonbooks.comAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Global supply chains, social commerce, geopolitical tensions, and now artificial intelligence (AI), are transforming the counterfeit landscape. Fake goods are no longer just a brand issue; they're a public policy issue, a security issue, and increasingly, a technology issue.Counterfeit goods affect everything from consumer safety and innovation to economic growth and organized crime. It's a public policy issue and it's evolving at speed.To help make sense of this shifting terrain, we talk to Chloe Long, Director‑General of the Anti‑Counterfeiting Group (ACG), one of the world's leading organizations dedicated to protecting intellectual property (IP) and brand integrity.Ms. Long has played a central role in shaping the ACG's strategic direction—working closely with brands, enforcement agencies, policymakers, and international partners to tackle illicit trade and raise awareness of its real‑world impacts.She also joined this conversation—which took place in London during INTA's 2026 Annual Meeting—at a pivotal moment for the organization, following the recent announcement of her appointment as Director‑General, a role in which she is guiding the ACG through what may be its most complex and consequential chapter yet.In this episode of Brand & New, we'll explore the ACG's mission and day‑to‑day work, the latest trends in counterfeiting, how AI is changing both the threat and the response, and how the IP community is rising to the challenge and reshaping the global fight against fakes.Related ResourcesAbout Chloe LongAbout the Anti‑Counterfeiting GroupCounterfeiting in the UK (INTA Daily News, May 2026)Counterfeiting Fact Sheet (INTA, November 2025)INTA's Unreal CampaignRecent and Related Episodes of Brand & New Intelligence-Led Enforcement: How the UKIPO Is Rewriting the Playbook on IP CrimeInside the Dupe Revolution: Part 1Recent INTA Research for Intellectual Property ProfessionalsMapping Illicit Trade: Routes and Insights (INTA, June 2026)

China is entering a new demographic era, with one of the world's fastest-ageing populations reshaping its economic and social landscape. At the same time, advances in genetics, regenerative medicine and preventive health are deepening the understanding of ageing and healthy living. As science and policy evolve, what will it take to realize the full potential of longevity? Speakers: Chavalit Frederick Tsao, Chairman, TPC (Tsao Pao Chee) Group Kevin Strain, President and Chief Executive Officer, Sun Life Financial Inc. David Jacob, Chief Executive Officer, Marsh Asia, Marsh Liu Qian, Founder and Chief Executive Officer, Wusawa Advisory, Inc This is the full audio from a session at the Annual Meeting of the New Champions 2026 in Dalian, China on 23-25 June, 2026. Watch it here: https://www.weforum.org/meetings/annual-meeting-of-the-new-champions-2026/sessions/ageing-as-an-economic-asset/   Check out all our podcasts on wef.ch/podcasts:  YouTube - https://www.youtube.com/@wef/podcasts Radio Davos - subscribe: https://pod.link/1504682164 Meet the Leader - subscribe: https://pod.link/1534915560 Agenda Dialogues - subscribe: https://pod.link/1574956552  

Featuring perspectives from Dr Gottfried E Konecny and Dr Brian M Slomovitz, including the following topics: Introduction (0:00) Preventing Ovarian Cancer (1:04) Endometrial Cancer (5:27) Ovarian Cancer (25:36) Cervical Cancer (54:04) CME information and select publications

85 Years of sharing the best of Columbus with the world. In this episode, Boxer and Sarah have a grounded conversation with Brian Ross, President and CEO of Experience Columbus and Amir Eylon, President and CEO and Partner at Longwoods International, about the undeniable growth of Columbus' tourism economy. Brian's Bio:Brian Ross serves as president and CEO of Experience Columbus, the destination marketing organization for the Columbus region dedicated to growing visitor spending and enhancing the visitor experience. In his role, Ross leads the Experience Columbus team in growing the local travel economy through targeted destination sales and marketing strategies aimed at attracting conventions, trade shows, meetings and leisure visitors to Ohio's capital city. Under his leadership, the industry has grown to record highs. Annually, visitors make 54.9 million trips to Greater Columbus for conventions, trade shows, sporting events and leisure visits, spending $8.2 billion and supporting more than 82,500 jobs. Ross assumed the leadership role in 2013 after serving as the organization's vice president of sales for six years. A graduate of The Ohio State University, Ross worked for 17 years for Hyatt Hotels and Resorts in sales and marketing, including two stints at the Hyatt Regency Columbus. His last job with the company was as executive director of sales, overseeing 25 hotels in the western region.  At Experience Columbus, Ross has led the team to continually raise the profile of Columbus as a premiere destination. In 2024, Experience Columbus launched a new brand campaign, Yes, Columbus, which invites visitors to Columbus to experience the city firsthand and see why Columbus has been quietly stacking up accolades from top national outlets in recent years. In 2025, Columbus was recognized for the second year in a row as one of the top 10 best big cities in the U.S. according to Condé Nast Traveler's Readers' Choice Awards and was named one of America's next great food cities by Food & Wine. Ross has also led the team to continue to raise the profile of Columbus as a premiere destination for hosting meetings and conventions. In 2025, Columbus hosted a total of 349 conventions, trade shows and sporting events, up 3% from the previous year. Major recent events hosted in Columbus include the African Methodist Episcopal (AME) Church's General Conference, which brought 15,000 attendees, filled 22,000 hotel rooms and had an estimated $15 million in direct visitor spending. In 2023, Columbus hosted PCMA Convening Leaders as well as the U.S. Conference of Mayors. Columbus is proud to soon be a two-time host for ASAE's Annual Meeting & Exposition (in 2019 and returning again in 2030). Ross is an active member of industry organizations, which has further elevated Columbus' profile in the global tourism sector. He previously served on the Board of Directors for Destinations International, TourismOhio Advisory Board and the Franklin County Convention Facilities Authority. He and his wife, Mary, have one son and two dogs. They enjoy living in Columbus' Arena District, where they embrace an urban lifestyle with a wealth of festivals, neighborhoods, restaurants and entertainment within walking distance. Amir's Bio:PRESIDENT & CEO, PARTNERLONGWOODS INTERNATIONALA 37-year veteran of the Travel & Tourism industry, Amir Eylon is President & CEO of Longwoods International, a premier market research consultancy that specializes in the travel and tourism industry. In this role, he oversees all aspects of daily operations, thought leadership, product & business development, and partnerships for this recognized brand in tourism market research. Under his leadership, the company has more than doubled in size in terms of clients and team members.Amir joined Longwoods international in 2015 from his previous role as Vice President, Partner Engagement with Brand USA, the public-private partnership serving as the destination marketing organization dedicated to increasing international visitation to the US. He led the team responsible for helping to increase its partnership base and focused on exceeding service expectation for those partners. During his tenure, Brand USA grew its base from 15 to over 475 partners, comprised of destination marketing organizations, state tourism offices, attractions, hotels, travel brands, airlines, and tour operators.Prior to joining Brand USA, Amir served as Director of the Ohio Office of Tourism. Under his leadership, the state's marketing programs realized a tremendous return on investment and contributed to the growth of the state's then  $40 billion tourism economy. These successful marketing efforts were often cited as the basis for the program's many awards and recognitions during his tenure.He has also served as President of the Ohio Hotel & Lodging Association, Assistant Director of the Ohio Tourism Division, and Sales & Marketing Manager with the Steuben County Conference and Visitors Bureau.Amir is a regular speaker on market research and tourism at conferences and events around the country. His thoughts on the tourism industry and travel trends are often quoted in the media, and he has appeared in dozens of interviews among many national media outlets such as CNBC, MSNBC, WSJ, Forbes, the New York Times, the Washington Post, and the Los Angeles Times, and is a regular guest on many industry-related podcasts.Amir has been recognized with a number of Industry honors including Top 25 Extraordinary Minds in Sales & Marketing award (2014) by the Hospitality Sales and Marketing Association International (HSMAI); The Ohio Tourism Industry's Highest Honor, The Paul Sherlock Award; and The State of Ohio Distinguished Service Medal. He is an active member of many Travel Industry committees and task forces, a former Board Member of the U.S. Travel Association, and currently serves as the Immediate Past Board Chair for the Destinations International Foundation..Amir holds a Bachelor of Arts degree in Political Science from the University of Dayton and resides in Columbus, OH with his wife, Karen, who is also in the travel industry.

New York City Public Schools announced one of the most restrictive AI policies in the country, and LAUSD followed with a quiet moratorium of its own. For any company selling AI-powered tools into K-12, this isn't background noise anymore. It's a sign that the ground rules are being rewritten in real time, and positioning needs to keep up.At the same time, October is arriving with a full plate. Conference season, award deadlines, and the usual run of thematic days are all stacking on top of each other. It's worth asking a harder question before the calendar takes over: which of these deadlines actually matter, and which ones are just habit?This field notes episode covers what's moving fast right now, the AI policy shifts landing in New York City and Los Angeles, the conference and award deadlines worth prioritizing this fall, and what actually earns a response on LinkedIn.What You'll Learn1️⃣ Why NYC and LAUSD's AI policies matter beyond their own districtsNew York's policy sounds like a blanket ban, but it's more nuanced than the headlines suggest. Teachers can still use AI to plan lessons, translate, and communicate with families, they just can't use it to grade, decide who graduates, or counsel a student in crisis. LAUSD's own moratorium on student use of generative AI arrived quietly enough that it reportedly surprised its own school board. When the country's largest districts move first, others tend to follow.2️⃣ What's worth prioritizing on a packed fall conference and awards calendarDA Awards entries close October 1st, EdTech Week runs October 13th - 14th, FETC's prices increase October 30th, and SXSW EDU's Launch competition deadline is November 1st, on top of national conferences like NCTM in Denver and CGCS in Boston. This episode breaks down which deadlines are worth building a strategy around, rather than trying to hit everything.3️⃣ What new findings say about getting a response to a LinkedIn connection requestRichard Vanderblom's poll and analysis found that a "helpful" message, one that references something specific about the person's post, is what actually gets a response. It's a small shift, but one that changes how outreach on the platform should be built.Why It MattersEducation marketers are heading into one of the busiest stretches of the year with less room for error than usual. Districts are rewriting AI policy in real time, marketing calendars are more crowded than usual, and the platforms relied on for organic reach keep changing what earns attention. None of this is a reason to freeze. It's a reason to get more deliberate, know which policy shifts touch a given product, spend fall's limited time and budget on the deadlines that matter most, and build outreach around what's genuinely earning a response right now.Resources Mentioned in this Episode:Operation Bluebird Launches Twitter.nowA new social platform reviving the Twitter name and bird logo, from a startup co-founded by former Twitter trademark counsel Stephen Coates, and referenced as the latest in a long line of platforms trying to pull people away from X.LinkedIn Adds AI-Powered Event HighlightsCovers a new feature that automatically turns live event recordings into short-form clips and chapters, discussed as a reason to treat every livestream as an ongoing content engine.Metricool's 2026 State of AI in Social Media StudyThe report showing three in four social media professionals use AI daily, while only about 12% work under a formal company AI policy.Richard Vanderblom's LinkedIn Post on Connection RequestsA carousel and poll on what actually gets a response when reaching out on LinkedIn, with the finding that "helpful" outreach outperforms a generic pitch.The Marketing Millennials: The 4 Landing Pages You NeedDaniel Murray's article on the "Core Four" landing page framework and the "Hail Mary mistake" of sending cold traffic straight to a demo page.Leoni Consulting Group's Free Education Marketing Planner (reach out via LinkedIn or the contact page)Covers all of the October dates referenced in this episode, with the 2027 edition launching soon.AASPA Annual ConferenceThe American Association of School Personnel Administrators' conference, October 12 - 15 in Austin, TXEdTech WeekNYC's edtech festival, including the Shark Tank pitch competition and an invite-only CEO Summit.ALAS National Summit on EducationThe Association of Latino Administrators and Superintendents' national summit, October 15 - 17 in Denver, CO.CGCS 70th Annual Fall ConferenceThe Council of the Great City Schools' conference for district leaders, October 21 - 25 in Boston, MA.NCTM 2026 Annual Meeting & ExpositionThe National Council of Teachers of Mathematics' annual meeting, October 28 - 31 in Denver, CO.District Administration Awards of DistinctionThe awards program discussed in the segment on why an award strategy matters for credibility, even when clients don't think to apply on their own.FullScale SymposiumAn education innovation conference running October 8 - 10 in Indianapolis, IN.FETC 2027 RegistrationRegistration for the Future of Education Technology Conference, with prices increasing on October 30.SXSW EDU Launch Startup CompetitionThe pitch competition for early-stage education startups, with applications due November 1.Leoni Consulting Group's Dear Colleague Letter Roundup (post 1 | post 2 | post 3 | post 4)A collection of the most thought-provoking posts, articles, and podcasts on the Department of Education's recent "Dear Colleague" letter.NYC Public Schools' New AI and Screen Time Policy (official guidance | Chalkbeat coverage | NBC News summary of NYT reporting)Coverage of NYC's new AI policy, discussed in the closing AI policy segment.LAUSD's Generative AI Moratorium on Student Devices (syndicated LA Times coverage via Yahoo News | LAist coverage)Lisa Mo, 2026 Riverside County Teacher of the Year, on screen time, "it's not the plane, it's the pilot."Connect with Elana: LinkedIn

Featuring perspectives from Dr Aditya Bardia, Dr Kevin Kalinsky and Dr Joyce O'Shaughnessy, including the following topics: Introduction (0:00) Hormone Receptor-Positive Breast Cancer — Dr Kalinsky (1:18) HER2-Positive Breast Cancer — Dr Bardia (42:46) Triple-Negative Breast Cancer — Dr O'Shaughnessy (1:01:41) CME information and select publications

OEC's Drive-Thru Annual Meeting returns October 2 from 10 a.m. to 6 p.m. at the Lloyd Noble Center—and we're giving members everything they need to know before they arrive. Brianna and Daniel explain who can participate, what to bring and how OEC has fine-tuned the process to get members registered and back on the road in as little as 10–15 minutes.They also share what members will receive—including a $30 bill credit, OEC gifts and a chance to win one of four $500 grand prizes—and discuss why the Annual Meeting is about more than giveaways. It's an opportunity for OEC's member-owners to participate in their cooperative, connect with employees and remind us exactly who we work for.Learn more and RSVP at okcoop.org/AnnualMeeting

MAPS Chief Medical Officer Charlotte Kremer sits down with Dr. Bjorn Oddens, Senior Vice President, Value and Implementation at Merck, for a candid conversation on the career-defining moments, hard-won lessons, and mentors that shaped his path — plus his view on where Medical Affairs is headed over the next decade. About the Medical Affairs Professional Society (MAPS)The Medical Affairs Professional Society (MAPS) is the leading global authority and community for Medical Affairs professionals, uniting over 18,000 members across 400+ organizations in Pharmaceutical, Biotech, MedTech, and related industries. Founded in 2016, MAPS is a 501(c)(3) nonprofit dedicated to advancing careers and elevating the Medical Affairs profession worldwide. 

Featuring perspectives from Dr Floor J Backes, Dr Matthew A Powell and Dr Ritu Salani, moderated by Dr Salani, including the following topics: Case: A woman in her late 60s with recurrence of metastatic estrogen receptor-positive endometrial cancer enrolls in a trial of CDK4/6 inhibition with an aromatase inhibitor 1 year into maintenance dostarlimab after carboplatin/paclitaxel/dostarlimab and has no evidence of disease 3 years later (0:00) Adding a PARP inhibitor to immunotherapy and chemotherapy: The RUBY Part 2 and DUO-E trials (10:03) CME information and select publications

if you have any feedback, please send us a text! Thank you!Welcome back to Vital Times, the podcast of the California Society of Anesthesiologists. The news: CSA is launching its first Podcast Host Contest. We're looking for new voices for this show — and we're looking for it among you.Who's eligible: Anesthesiology residents and fellows at California programs. Medical students at California medical schools with a demonstrated interest in the specialty. Any year. All subspecialty tracks.No podcasting experience required. None. If you've never touched a microphone and you have something to say, we want to hear it. How to enter. Send us:An audio or video file, two to five minutes. Introduce yourself, or talk through a topic you care about. It doesn't need to be polished. We want to hear how you think and how you sound.A written statement, 250 to 500 words. Why hosting interests you. What you'd cover. Who you'd want in the room.Who's judging: selected members of the Communications Committee and staff. We're scoring on communication style, content knowledge, professionalism, enthusiasm, creativity, and alignment with CSA values.Why it matters. This is more than a published episode with your name on it or a line on your CV. It's mentorship — working with us on the craft of interviewing and the discipline of talking well about hard subjects. It's visibility across CSA, and a leadership network most trainees don't see for years. The winner is recognized in the CSA Newsletter, on our website, and at the Annual Meeting.And if you don't win: strong entries may be featured on the CSA website. Either way, you'll have made something that's yours.The bottom line. Sixty to ninety percent of residents already listen to podcasts monthly. Some of the people making them should be you.Submissions open September 9th and close November 9th. Send yours to csa@csahq.org.

News: NASA-ISRO NISAR SAR mission data products now available Geopera 2026 Bhote Koshe Flood open satellite data Cornell University's Cool Trees project releases first "Wall to Wall" map of city trees  Utility of GNIS continues to be eroded Geo Week event scholarship   Web corner: MiniTokyo3D Topic: Andres with Bootcamp GIS Summers and Mary of BlueRaster Events: 2026 SWAAG Annual Meeting - September 30, Lubbock, TX Middle Atlantic Regional Division Annual Meeting - November 20, Belair, MD 2026 Annual Meeting of SEDAAG - November 22-23, Tuscaloosa, AL   Music: "It's All Wrong (It's Alright)" by Cardboard Cat  

On this episode of the IPhO Podcast, we are highlighting how the IPhO Annual Meeting can help students prepare for the industry fellowship process. We are joined by Jenna Brady, PharmD, a first-year Medical Affairs Fellow at GSK in affiliation with the University of North Carolina at Chapel Hill. Jenna shares her experience attending the IPhO Annual Meeting last year and how it helped prepare her for fellowship applications. She discusses how the Annual Meeting provides students with opportunities to connect with current fellows and industry professionals, learn more about various fellowship programs, and gain valuable insights ahead of the application process. The IPhO Annual Meeting will take place September 17–20, 2026. Don't miss this opportunity to connect with industry professionals, expand your network, and prepare yourself for the upcoming fellowship season!

As an astronaut, Samantha Cristoforetti knows a lot about leadership and teamwork. She spoke to our sister podcast Meet the Leader at the Annual Meeting in Davos in January. You can watch it here: https://www.youtube.com/watch?v=AI_7QcZy5A8 and find a transcript and more information here: https://www.weforum.org/podcasts/meet-the-leader/episodes/samantha-cristoforetti-esa-teamwork-leadership/ Check out all our podcasts on wef.ch/podcasts:  YouTube - https://www.youtube.com/@wef/podcasts Radio Davos - subscribe: https://pod.link/1504682164 Meet the Leader - subscribe: https://pod.link/1534915560 Agenda Dialogues - subscribe: https://pod.link/1574956552    

On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more... Check out all of our events like Moms' Night Out and Club 1921 here. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  On this episode of Diabetes Connections In the news… The FDA approves a new indication and health benefit for Mounjaro, lots of CGM news including an update on Medicare coverage for people who don't use insulin and a new study about using CGM when you don't have diabetes, metformin and aging, statins and type 2, and did you know there was a Dolly Parton diabetes connections? That and much more.. that's coming up right after this. (AD BREAK) Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bring you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Welcome to September! Want to let you know about a webinar I'm doing with Abbott later this month. That's Sept 23 at 7pm ET. We'll be talking about ketones, DKA and learn more about their dual CGM/ketone monitor that was just approved – more on that coming up. But please register – the link is in the show notes. So much going on over here – tomorrow night we have our Club 1921 in Charlotte, later this month Moms' Night Out Detroit/Bloomfield and in October we're going to Seattle. Please join us. More at d-c dot com slash events. Okay.. our top story this week: XX Another indication for Mounjaro – the FDA approved it to lower the risk of major adverse cardiovascular (CV) events (MACE), including CV death, non-fatal heart attack, or non-fatal stroke in adults with type 2 diabetes who are at high risk for these events. Mounjaro – the brand name of tirzepatide - is already approved as an adjunct to diet and exercise to improve blood sugar in adults and children 10 years of age and older with type 2 diabetes. The approval was based on results from the largest and longest tirzepatide study to date, enrolling more than 13,000 participants across 30 countries over more than four and a half years. In the trial, Mounjaro demonstrated non-inferiority to Trulicity (dulaglutide), a GLP-1 treatment with established cardiovascular benefit, with an 8% lower rate of cardiovascular death, heart attack or stroke (MACE-3). The estimated hazard ratio for time to first MACE was 0.92 (95.3% CI: 0.83, 1.01) for Mounjaro compared to Trulicity (dulaglutide). https://www.prnewswire.com/news-releases/fda-approves-lillys-mounjaro-tirzepatide-to-reduce-cardiovascular-risk-in-adults-with-type-2-diabetes-302862415.html XX The FDA approves the Libre Duo – the first device designed to continuously monitor both blood sugar levels and ketone levels in people with diabetes. The Libre Duo 10-Day Continuous Dual Glucose Ketone Monitoring System is now approved for those ages 2 and older. Until now, the agency said, people had to monitor ketone levels with separate tests that only provided a single measurement at one point in time. The new system combines blood sugar and ketone tests and monitors them continuously. Readings -- and alerts in case of dangerous trends -- are sent wirelessly to a smartphone app. The FDA previously granted "breakthrough device" status to the system, which is meant to expedite the device's development and review. https://www.upi.com/Top_News/US/2026/08/25/fda-oks-blood-sugar-ketone-monitor/5521787688375/ XX Diabetes tech firms Dexcom and Abbott are watching closely for a Medicare coverage expansion that could significantly broaden access to their glucose sensors. The Centers for Medicare and Medicaid Services is expected to expand Medicare coverage of continuous glucose monitors to people with diabetes who do not take insulin. Currently, coverage is limited to people with Type 1 or Type 2 diabetes who take insulin or have a history of problematic low blood sugar. Dexcom CEO Jake Leach told investors in a late July earnings call that the company expects to hear back from the CMS before the end of the year, with coverage going into effect in mid-2027.     Dexcom presented results of a randomized, controlled trial earlier this summer at the American Diabetes Association's Scientific Sessions that it expects will support the CMS' decision. The 26-week study found that people who used a CGM had a larger hemoglobin A1C reduction than the control group and spent five more hours per day in a normal glucose range than the control group. https://www.medtechdive.com/news/dexcom-abbott-await-medicare-coverage-expansion-for-cgms/828775/ XX A new study suggests continuous glucose monitors (CGMs) may offer benefits for people with type 1 diabetes that go beyond improving blood sugar and reducing hypoglycemia.   Researchers analyzed health records from more than 8,400 adults with type 1 diabetes receiving care through the Veterans Health Administration. Over one to four years of follow-up, people who started using a CGM had a 10% to 16% lower risk of death from any cause compared with those who did not use one.   The association appeared strongest among people over age 65 and those who were not using insulin pumps. Researchers did not find meaningful differences based on A1C, race or ethnicity, or frailty.   Importantly, this was an observational study using medical records, not a randomized clinical trial, so it cannot prove that CGM use directly caused the lower death rate. But the findings suggest CGM may have important long-term health benefits beyond glucose management.https://visualize.jove.com/42319755-continuous-glucose-monitoring-initiation-is-associated-with-reduced-mortality-in-older-onset-type-1-diabetes-patients-a-target-trial-emulation-study-within-the-veterans-health-administration XX We've been talking about people without diabetes using CGMs for a long time.. now a new study weighs in. Research published in JAMA finds that this wellness trend isn't helpful for people without a diabetes diagnosis. They found that the strongest evidence for CGM use is for people who are already living with diabetes, but not for those without the condition who use them for wellness purposes. It's also worth noting, though, that this new study is a narrative review. This means that the researchers drew their conclusions from the findings reported in several other studies. More randomized controlled trials would be necessary to see whether there are any meaningful health benefits of using a CGM if you don't have diabetes.   Dower also warned that constantly monitoring your blood sugar when you don't have diabetes could lead to unintended health anxiety. In some cases, you may even make accidental lifestyle changes that could be harmful. "[Blood sugar] spikes may occur after meals, but if this leads someone to replace healthy food such as fruit with unhealthy food such as something high in fat but low in carbohydrate, the glucose information has done more harm than good," Dower said. https://www.verywellhealth.com/blood-sugar-monitor-for-people-without-diabetes-12058575   XX   Could metformin somehow influence the biological processes that drive aging? A new review found evidence that metformin may affect several key features of aging, including how cells use energy, inflammation, cellular damage and even some changes in gene activity. Animal studies have shown longer lifespans or improvements in markers of biological aging, while some human studies have also found promising results.   But researchers say there's still no proof that metformin actually slows aging or helps healthy people live longer. Most human research has involved people with diabetes or other health conditions, and one large trial found that while metformin helped prevent type 2 diabetes, it did not reduce cancer, cardiovascular disease or deaths.   Researchers say larger clinical trials in people without diabetes are needed to determine whether metformin can truly extend healthy lifespan—or whether its benefits are primarily related to preventing and treating specific diseases. https://www.technologynetworks.com/drug-discovery/news/metformin-may-influence-longevity-through-the-gut-microbiome-and-epigenetic-changes-416035 XX More to come including more research on a spice thought to help diabetes, predictions about the number of people who may be living with type 1 in the years to come around the world, and a connection I didn't know about between diabetes and Dolly Parton.   XX A compound found in turmeric may help protect blood vessels from some of the damage caused by Type 1 diabetes. In rats, curcumin reduced inflammation, improved cellular signaling, and restored vascular health to levels resembling those of nondiabetic animals. The results hint at a possible new way to reduce the long-term cardiovascular risks of diabetes, but human trials are still needed. Curcumin, the natural compound responsible for turmeric's vivid yellow color, is widely studied for its anti-inflammatory and antioxidant properties. https://www.sciencedaily.com/releases/2026/08/260824065543.htm XX New research estimates the number of people living with type 1 diabetes (T1D) worldwide will increase by 29% from 9.4 million in 2025 to 12.1 million in 2049. This will be presented at EASD, the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2 The USA will see an increase of over half a million, going from 1,492,825 to 2,055,235. The authors suggest that the reasons for the predicted high incidence and prevalence in 2049 in countries such as Australia, US, UK are likely to be a combination of genetics, environmental triggers and also high case detection rates (due to the good health care infrastructure here and in other HIC). Unlike previous estimates, the DIAMOND-T1D model takes historical patterns of insulin availability into account and aims to provide global, regional and country-specific estimates of T1D incidence, prevalence and mortality from 1900 to 2050. Although the majority of people with T1D live in high-income countries (HIC) and middle-income countries (MIC), the largest relative increase in the T1D prevalence is expected to occur in LIC as access to insulin, glucose monitoring and survival all improve in those countries. https://www.news-medical.net/news/20260828/Type-1-diabetes-cases-projected-to-increase-worldwide-by-2049.aspx XX Early initiation of statins after a diagnosis of type 2 diabetes was associated with a lower risk of dementia, according to a study published in The Lancet Regional Health – Europe. According to the Lancet Commission, nearly half of dementia cases could theoretically be prevented by eliminating 14 risk factors. "Detecting and treating high levels of low-density lipoprotein cholesterol (LDL-C) from midlife is one such highlighted risk factor," From Danish registers, researchers identified 132,585 statin-naive individuals who developed type 2 diabetes from 2006 through 2019, with follow-up until the end of 2021.   Medical records were searched for diagnoses of all-cause dementia. A clone-censor-weight design was used to analyze dementia incidence in patients with no statin initiation within five years after diagnosis, in those with early statin initiation within one year and in those with late statin initiation between one and five years after diagnosis.   https://medicalxpress.com/news/2026-08-early-statins-diagnosis-diabetes-dementia.html   XX We are heartbroken over the loss of our friend Dolly Parton. Dolly was a beloved icon whose extraordinary generosity, warmth, and compassion touched countless lives, including those of the Children's Diabetes Foundation and the Barbara Davis Center for Diabetes. Her support of The Carousel Ball and Carousel of Hope Ball reflected her deep commitment to helping children and families affected by type 1 diabetes. Beyond her remarkable talent, Dolly will be remembered for the kindness and joy she shared so generously with others. Our hearts are with her family, friends, and all who loved her as we celebrate her extraordinary life and lasting legacy. She will be deeply missed.    

DR'We Know We Got This Wrong': Target Apologises and Pulls 'Offensive' Halloween Costume After Racist Backlash; Target Executive Chair Brian Cornell Sells 50,000 Shares for $8.2 Million; WHO DO YOU BLAME?Executive Chair/former CEO (since 2014) Brian Cornell: still 21% influence!CEO Michael Fiddelke: 16% influence; started at Target in 2003; formerly COO and CFOWhy does the corporate page not list his years of service in two separate bios??Dmitri Stockton: 8 years tenure; the double-DEI hater (Deere & Company) Mr. Stockton provides the Board with senior leadership, marketing / design / brands, human capital management, capital deployment, information security / data privacy, financial management, risk management, reputation management, and sustainability and governance skills developed over his more than 30 years of service with General Electric Company in senior leadership positions with escalating levels of responsibilityMarketing / Design / Brands: Target's brand and focus on style and design are the cornerstones of our strategy to offer a preferred shopping experience for our guests that differentiates us in the marketplace.Reputation management: To be successful, we must preserve, grow, and leverage the value of our reputation with our guests, Team Members, vendors, and our shareholders and appropriately respond to crisis events affecting them.A random executive?Chief Merchandising Officer Cara Sylvester: joined Target in 2007Chief Community and Stakeholder Engagement Officer Kiera Fernandez: joined Target in 2001Chief Stores Officer Adrienne Costanzo: joined Target in 2004Black CFO representation falls 25% from 2021 peak as diversity levels off: The number of Black finance chiefs in Fortune 500 and S&P 500 companies ticked down to 15 this year, according to the report from Crist Kolder Associates. WHO DO YOU BLAME?Tractor Supply Co.: Fully eliminated its DEI goals, retired carbon emission targets, and withdrew sponsorships from social and cultural events.Deere & Company: Ended participation in social awareness parades and pledged to eliminate diversity quotas and identity-based affinity group funding.Target: Scaled back its "Racial Equity Action and Change" roadmap, modified its strategy for Pride Month merchandise, and adjusted internal diversity goals.Walmart: Ended key equity training programs, modified its third-party seller guidelines, and scaled back specific minority supplier programs.Lowe's: Ended participation in external LGBTQ+ advocacy surveys and consolidated its employee resource groups under a centralized oversight structure.Ford Motor Company: Scaled back internal diversity targets, stopped participating in third-party workplace index surveys, and unlinked executive pay from DEI metrics.Harley-Davidson: Discontinued its dedicated DEI function, eliminated diversity quotas for supplier contracts, and ended HRC index reporting.Molson Coors: Removed DEI quotas from executive incentive plans and stepped back from external diversity rankings.Meta: Reorganized its human resources departments, eliminating specialized DEI teams and specific supplier diversity programs in favor of broader recruitment practices.Amazon: Phased out several internal affinity programs and explicit representation targets for hiring.McDonald's: Retired numerical demographic goals for senior management roles and paused external workplace diversity surveys.Goldman Sachs: Ended its policy requiring companies it takes public to have at least one diverse board member.The double (and triple?) dippers:Dmitri Stockton: director at Target & DeereJohn May CEO/Chair Deere & Ford Motor directorMarvin Ellison: CEO/Chair at Lowe's after 15 years at TargetJim Farley: CEO Ford Motor & McDonald's director & former Harley-Davison director MMTrump 2.0/ElonShareholder opposition to executive pay eases globallyEurope: NO VOTES for past year fell nearly 6 percentage points year-over-year to 25.2%, the lowest average level since at least 2018.United States: Say on Pay Average Support (S&P 500): Rose to 90.4% (up from 89.7%). Failed Votes (12 years tenure, only 4 of the 11 directors got tagged as having meritThe number of committees - SIX different committees with SIX members in each (except audit which is 5) for 10 directors at the time - they needed to add ANYONE because they were exhausted from so many committee meetingsRich Stoddart DRMember of Nom/CG (also Audit, “Innovation”, and “Social Responsibility”)Was CEO of Leo Burnett - advertising agency that handled massive portion of Nestle USA advertising. Presley was CEO of Nestle USA.Callaway Golf CEO met with backlash over apology for Good Good video depicting abuseThe ad: In the footage, Good Good personality Garrett Clark charges at Alexis Miestowski, knocks her onto the grass, then stands over her and says, "Do not touch my new driver."The company issued a statement on Friday, but CEO Chip Brewer did a social media post this morning stating: "That approval should never have happened. Mistakes were made, and we are taking the matter very seriously. I want to make it clear that we sincerely apologize for the video." He did not apologize to women.WHO DO YOU BLAME?EVP and President of Callaway Golf Glenn Hickey who leads sales and marketing, whose prior work includes being a bond trader and getting a business degree from San Diego State, but was absent for the “don't shove a woman in an ad” lesson (possibly)Good Good and its CEO Matt Kendrick who made the ad for Callaway and posted, “Interesting that @CallawayGolf asks us to make an ad then approves it then asks us to take the fall then drops us in a coordinated media blitz and covers it up by giving a million dollars away thinking everyone will be ok with it. 30 for 39 will be legendary.” He also apologized. But clearly more annoyed at Callaway than, you know, sorry for women?The women on the board and the management team - they should have caught this before it got out! Oh, what? There's TWO women on the board (one auditor who is ex-Boeing, a company with no challenges, and the other a Chief People Officer at a food company) and ONE woman in management (Chief People Officer)? None of whom would have seen the ad??? Oops.Tom Dundon - who, according to the Callaway 2026 Proxy Statement, has been a director since “not applicable” - but does own more than 10% of the stock and has 56% influence over the company according to Free Float data MM

In this special episode of Front Porch Chats, we're taking a look at the State of the Co-op — where Flint Energies is today, where we're headed, and what it all means for our members and the communities we serve. From growth and reliability to infrastructure investments, community impact, economic development and preparing for the future, we're pulling back the curtain on the people, priorities and decisions that keep the cooperative moving forward. Because the state of the co-op isn't just about numbers — it's about the members, families, businesses and communities that make Flint Energies what it is.Also, please join us for our Annual Meeting on Tuesday, October 6, 2026, at Southside Baptist Church (1040 S. Houston Lake Rd. Warner Robins, Georgia). Doors open at 8:30 a.m., and the business meeting begins at 10:00 a.m. The first 1,000 members will receive a member appreciation gift. You'll also enjoy music provided by the Southside Baptist Church Worship and Praise Band, coffee and donuts, as well as a complimentary BBQ lunch.

The Capital District Area Labor Federation (CDALF) Annual Meeting took place on Saturday, April 25, 2026, bringing together union leaders, delegates, and frontline workers across the Capital Region to organize and advocate for workers' rights. Roaming Labor Correspondent Willie Terry covered the event. In this labor segment on the upcoming Labor Day in September 2026, he played a recorded speech from Mark Emanatian, CDALF Executive Director, on the importance of Unions and active union membership, which Mark gave at the CDALF Annual Meeting on April 25. 2026. This is part one of two.

The Capital District Area Labor Federation (CDALF) Annual Meeting took place on Saturday, April 25, 2026, bringing together union leaders, delegates, and frontline workers across the Capital Region to organize and advocate for workers' rights. Roaming Labor Correspondent Willie Terry covered the event. In this labor segment on the upcoming Labor Day in September 2026, he played a recorded speech from Mark Emanatian, CDALF Executive Director, on the importance of Unions and active union membership, which Mark gave at the CDALF Annual Meeting on April 25. 2026. This is part one of two.

Margery Kraus is the Founder and Executive Chairman of APCO Worldwide, a company she started in 1984 as a small subsidiary of a Washington, D.C. law firm and built into a global consultancy with roughly 1,200 people across 35 locations.Her story, though, starts much earlier. The child of immigrants whose family fled Nazi Europe, passed through Cuba and eventually rebuilt their lives in America, Margery grew up around resilience, risk and starting again.We talk about how that shaped the entrepreneur she became, why she refused to listen when people told her “you can't do that,” and what it was really like building a global company while raising a family.We also get into the 2004 management buyout that helped make APCO one of the world's largest majority women-owned consulting firms, how you step back from leading a company you built without really letting go, and what four decades advising some of the world's most influential leaders have taught her about who thrives under pressure and who doesn't.Recorded in Dalian, China, during the World Economic Forum's Annual Meeting of the New Champions, we also look at the world right now: China's place in the global economy, shifting trade relationships and what the rest of the world may be getting wrong about this moment.And then there's AI. Margery says it's the thing that keeps her up at night. For someone who has built a career and a business around human trust, judgment and relationships, I wanted to know why.A fascinating conversation with someone who has spent more than 40 years building, adapting and refusing to stand still.Special thanks to the World Economic Forum for bringing us together in Dalian.

In this episode of AAHKS Amplified, host Cory L. Calendine, MD had the pleasure of sitting with Jenna Harrington of Vertex Pharmaceuticals to discuss JOURNAVX® (suzetrigine). Vertex won the 2025 AAHKS Industry Innovation Award. An award presented each year at the AAHKS Annual Meeting to companies with cutting-edge innovations in the field of orthopaedic hip and knee arthroplasty by exhibitors.  Journavx is an oral, non-opioid, highly selective pain signal inhibitor that is selective for NaV1.8 relative to other NaV channels. Because JOURNAVX blocks pain signals only found in the periphery, not in the brain, JOURNAVX provides effective relief of pain without the limitations of currently available therapies, including the addictive potential of opioids. For more information on Journavx and how they are transforming the landscape of pain management, tune in for the full recording. Don’t forget to subscribe and thanks for listening to AAHKS Amplified! In This Episode:Cory L. Calendine, MD Jenna Harrington  The post Vertex Pharmaceuticals' Journavx Wins Award at 2025 AAHKS Annual Meeting first appeared on AAHKS.

In this episode of the NCS Podcast Hot Topics series, host Eric Lawson, MD, speaks with NCS Vice President and Annual Meeting Planning Committee Chair Lori Shutter, MD, FNCS, for a preview of the NCS 24th Annual Meeting, taking place Oct. 20-23 in Seattle. Dr. Shutter discusses this year's theme, "Reaching New Heights: Advancing the Future of Neurocritical Care," and how it reflects the Society's continued growth and optimism about the future of the field. The conversation offers a look at expanded workshop offerings, including sessions on the essentials of neurocritical care, critical care procedures, point-of-care and neurofocused ultrasound, and informatics and big data. Dr. Shutter also previews keynote addresses from Walter Koroshetz, MD, and Lisa Meeks, PhD, along with sessions focused on clinical trials, physiology, pediatric neurocritical care, global health, professional development and sustainability in the ICU. Listeners will also learn about opportunities for first-time attendees and new members, the return of the leadership closing panel and an open brainstorming session focused on the Society's next major area of research. Dr. Shutter shares how attendee feedback shaped this year's program and offers advice for making the most of the meeting's concurrent sessions, networking opportunities and special events. The views expressed on the NCS Podcast are solely those of the host and guest and do not necessarily reflect the opinions or official positions of the Neurocritical Care Society.

Featuring perspectives from Dr Rahul Aggarwal, Dr Matthew D Galsky and Dr Tian Zhang, including the following topics: Introduction: Welcome GU Oncology Fellows! (0:00) Prostate Cancer — Dr Aggarwal (12:48) Urothelial Bladder Cancer — Dr Galsky (45:01) Renal Cell Carcinoma — Dr Zhang (1:10:52) CME information and select publications

Recorded live at the ASGCT 2026 Annual Meeting in Boston, Le Cong, PhD joins hosts Jason West, PhD and Sanjay D’Souza, PhD for a discussion on his work in genome engineering and the early development of CRISPR/Cas9. The three then dive into Dr. Cong’s use of artificial intelligence tools developed and currently used by his lab. Dr. Cong is a 2026 recipient of ASGCT’s Outstanding New Investigator Awards. Music: ‘Bright New Morning’ by Steven O’Brien – released under CC-BY 4.0. https://www.steven-obrien.net/Show your support for ASGCT!: https://asgct.org/membership/donateSee omnystudio.com/listener for privacy information.

Fertility and Sterility on Air is at the European Society of Human Reproduction and Embryology 42nd Annual Meeting in London (Part 3)! In this episode, our hosts Micah Hill and Eve Feinberg cover: (00:56) Cost-to-baby as a percentage of median household income predicts population-level access to assisted reproductive technology: a global health economics analysis of affordability with Steve Rooks  (12:50) Intrapatient variability in the number of retrieved oocytes and ovarian response categories between consecutive in vitro fertilization cycles with Ariel Hourvitz (30:11) Restoring Shugoshin-1 prevents chromosomal errors in aging human oocytes with Agata Zielinska (45:32) Restoring fertility after gonadotoxic treatment: first successful autologous transplant of immature cryopreserved testicular tissue in the human with Veerle Vloeberghs and Ellen Goossens

Mazen S. Darwazeh is the Executive Chairman and Deputy Chief Executive Officer of Hikma Pharmaceuticals, and a Jordanian senator currently serving his fifth term.His journey with Hikma began in 1985 as a medical representative.Over the next four decades, he rose through the company to lead its MENA business and help shape Hikma into the largest pharmaceutical company by sales in the region and a FTSE 100 multinational employing around 9,500 people across three continents.Recorded in Dalian, China, this conversation was made possible thanks to the World Economic Forum, who facilitated the episode during the Annual Meeting of the New Champions.On this episode, we talk about what it takes to preserve the values of a family-built company as it becomes a global institution, Hikma's ambitions for healthcare in the Middle East, the growing role of biosimilars and biotechnology, and the challenge of ensuring access to essential medicines in a region shaped by geopolitical uncertainty.We also discuss China's evolving role in the pharmaceutical industry, Mazen's perspective from both business and public service, and what four decades in healthcare have taught him about leadership, longevity and building something that lasts.

Featuring perspectives from Dr Jeremy S Abramson, Dr Joshua Brody, Dr Manali Kamdar, Dr Tycel Phillips and Dr Jason Westin, moderated by Dr Abramson, including the following topics: Introduction (0:00) Chimeric Antigen Receptor (CAR) T-Cell Therapy for Diffuse Large B-Cell Lymphoma (DLBCL) — Dr Kamdar (2:16) Bispecific Antibody Therapy for DLBCL — Dr Westin (27:21) CAR T-Cell Therapy for Other Lymphoma Subtypes — Dr Abramson (51:10) Bispecific Antibody Therapy for Follicular Lymphoma and Other Lymphoma Subtypes — Dr Phillips (1:13:24) Tolerability Considerations with CAR T-Cell Therapy and Bispecific Antibodies — Dr Brody (1:37:47) CME information and select publications

The Boone Area Chamber of Commerce hosts Spirit of Boone, its 77th annual membership gathering, September 24th in the Grandview Ballroom at Kidd Brewer Stadium.The full slate of honorees was announced on WATA's Mark in the Morning show on August 11th, marking the beginning of the storytelling about the accomplishments of this year's class. On this week's Mind Your Business, we unveil this year's list of honorees, and talk about what made them a choice for this year's spotlight. We also reconnect with Ashley Galleher, the 2025 Kathy Crutchfield Citizen of the Year award recipient, and we'll hear how ZRC Skate has been impacted over the last year by more through community awareness of this unique business.Mind Your Business is written and produced weekly by the Boone Area Chamber of Commerce. This podcast is made possible thanks to the sponsorship support of Appalachian Commercial Real Estate.Catch the show each Thursday afternoon at 5PM on WATA (1450AM & 96.5FM) in Boone.Support the show

Featuring perspectives from Dr Wassim Abida, Dr Rahul Aggarwal, Dr Emmanuel S Antonarakis, Prof Karim Fizazi and Dr Rana R McKay, moderated by Dr McKay, including the following topics: Introduction (0:00) Evolving Management of Nonmetastatic Hormone-Sensitive Prostate Cancer (HSPC) — Dr Antonarakis (2:42) Current and Future Hormonal Treatment for Metastatic HSPC (mHSPC) — Dr Aggarwal (26:23) Current and Future Role of Regimens Combining PARP Inhibitors and Androgen Receptor (AR) Pathway Inhibitors in Metastatic Prostate Cancer — Dr Abida (53:01) Emerging Role of AKT Inhibition for Patients with mHSPC — Prof Fizazi (1:17:22) Current and Future Use of Radiopharmaceuticals in Metastatic Prostate Cancer — Dr McKay (1:39:37) CME information and select publications

Featuring perspectives from Prof Claire Harrison and Dr Raajit K Rampal, including the following topics: Introduction (0:00) The Biopathophysiology of Myelofibrosis (MF) (2:19) Current and Future Clinical Decision-Making in the Absence of Severe Cytopenias — Prof Harrison (7:49) Managing MF for Patients with Anemia and Thrombocytopenia — Dr Rampal (35:00) Upcoming at European Hematology Association (EHA) 2026 (49:22) CME information and select publications

Fertility & Sterility on Air is at the European Society of Human Reproduction and Embryology 42nd Annual Meeting in London (Part 2)! In this episode, our hosts Eve Feinberg, Kate Devine, and Yannick Hurni cover:  (00:56) Trends in first-cycle and cumulative live birth rates in the United States with Alexandra Herweck, SREI Landmark Articles podcast host (09:05) Impact of health optimization on reproductive outcomes and looking ahead to new REI innovations with Jim Toner, ASRM Vice President (20:07) Multiple sonographic markers of endometrial receptivity are significantly altered after hormonal intrauterine device (IUD) use among reproductive-aged women with proven fertility with Said Daneshmand (32:22) Effect of natural versus programmed cycle on the risk of hypertensive disorders of pregnancy following frozen-thawed blastocyst transfer: a randomized clinical trial in ovulatory women with Fang Gu (40:51) A look ahead to the 2026 ASRM Annual Meeting and impact of lifestyle factors on ART with Amy Sparks, ASRM President-Elect (47:19) Evaluating the safety and efficacy of IVF add-ons with Sarah Lensen (56:33) Clinical relevance of high-level mosaicism after PGT-A: mosaic segmental aneuploidies drive unexpected live birth outcomes with Francesca Spinella (01:06:23) Letrozole versus clomifene, with or without metformin, for ovulation induction in women with polycystic ovary syndrome (LOCI): a multicentre, 2x2 factorial design, randomised controlled trial with Pedro Melo View Fertility and Sterility at https://www.fertstert.org/  

Featuring perspectives from Dr Anne Chiang, Dr Apar Kishor Ganti, Dr Luis Paz-Ares and Dr Misty Dawn Shields, moderated by Dr Shields, including the following topics: Introduction (0:00) Optimizing First-Line and Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer (SCLC) — Dr Shields (2:17) Management of Relapsed/Refractory SCLC — Dr Paz-Ares (33:24) Ongoing Investigation and Potential Role of Antibody-Drug Conjugates in SCLC — Dr Chiang (1:02:28) Management of Limited-Stage SCLC — Dr Ganti (1:31:54) CME information and select publications

Featuring perspectives from Dr Yelena Y Janjigian, Dr Manish A Shah and Prof Eric Van Cutsem, moderated by Dr Janjigian, including the following topics: Introduction (0:00) HER2-Targeted Approaches in Advanced Gastroesophageal Cancers — Prof Van Cutsem (2:08) Targeting CLDN18.2 in Advanced Gastroesophageal Cancers — Dr Shah (30:54) Available Immunotherapeutic Strategies for Advanced Gastroesophageal Cancers — Dr Janjigian (1:01:39) CME information and select publications

What are state attorneys general preparing to tackle next—and what should businesses be watching? In this episode, we recap key takeaways from the 2026 Attorneys General Alliance Annual Meeting, where state AGs, regulators, and industry leaders focused on the rapid evolution of AI, privacy, pricing, child safety, and public-private partnerships. From growing scrutiny of algorithmic and surveillance pricing to expanding expectations around AI governance, data practices, online child protection, and collaboration between government and industry, the meeting underscored that state AGs are continuing to expand their influence across emerging technologies and consumer protection. For companies, the message was clear: proactive engagement, strong compliance programs, and a clear understanding of evolving state priorities will be essential as enforcement continues to accelerate. Hosted by Simone Roach. Based on a blog post by Paul L. Singer, Abigail Stempson, Beth Bolen Chun, and Andrea deLorimier.

Drs. Avni Finn and Matthew Starr join to discuss their favorite presentations and topics from the 2026 ASRS Annual Meeting.

Featuring perspectives from Dr Jeremy S Abramson, Dr John N Allan, Dr Bita Fakhri, Dr Shuo Ma and Dr Mazyar Shadman, moderated by Dr Abramson, including the following topics: Introduction (0:00) Current and Future Role of Continuous Bruton Tyrosine Kinase (BTK) Inhibitor Therapy for Previously Untreated Chronic Lymphocytic Leukemia (CLL) — Dr Fakhri (2:22) Available and Emerging Approaches to Time-Limited Therapy for Treatment-Naïve CLL — Dr Allan (23:24) Optimal Management of Adverse Events with BTK and Bcl-2 Inhibitors; Considerations for Special Patient Populations — Dr Ma (56:31) Selection and Sequencing of Therapy for Relapsed/Refractory CLL — Dr Shadman (1:17:01) Chimeric Antigen Receptor T-Cell Therapy and Other Novel Strategies for CLL — Dr Abramson (1:38:24) CME information and select publications

(Please excuse any sound quality issues, as some interviews were recorded in a large hall where background noise and echoes were hard to avoid.) Fertility & Sterility on Air is at the European Society of Human Reproduction and Embryology 42nd Annual Meeting in London (Part 1)! In this episode, our hosts Micah Hill and Yannick Hurni cover:  (01:49) ASRM President Robert Brannigan on the effect of lifestyle factors on male fertility and a look ahead at the 2026 ASRM Annual Meeting (07:25) The 2-shot protocol: a randomised controlled trial of a novel two-injection ovarian stimulation strategy with Valeria Donno (14:49) Paired trophectoderm and ICM analysis redefines segmental aneuploidy and embryo usability in poor-prognosis IVF patients with Balsam Al Hashimi View Fertility and Sterility at https://www.fertstert.org/  

Featuring an interview with Dr Ramez Eskander, including the following topics: Overview of antibody-drug conjugates (ADCs) and their role in the management of gynecologic cancers; considerations in sequencing (0:00) Choosing between FRɑ- and HER2-directed ADCs for dually eligible patients; role of antigenic target in predicting efficacy benefit of ADCs (7:53) Comparative efficacy and safety of ADCs and conventional chemotherapy (12:58) Current and investigational targets of ADCs in gynecologic cancers (17:14) Current research surrounding raludotatug deruxtecan (R-DXd) and its potential role in clinical practice (21:56) Safety and tolerability profiles of ADCs, including R-DXd, and potential mitigation strategies (27:36) Overview of available TROP2-directed ADCs for gynecologic cancers, including key clinical data (33:34) Evolving use of TROP2-directed ADCs for gynecologic cancers in clinical trials (39:05) Oral mucositis/stomatitis associated with TROP2-directed ADCs and potential mitigation strategies (44:38) CME information and select publications

Send us Fan MailWhat were some of the biggest metastatic breast cancer updates from the 2026 ASCO Annual Meeting and which findings are already changing care?In this episode of OUR MBC Life, Dr. Chen breaks down key research findings and what they mean for people living with metastatic breast cancer. This episode also includes a Q & A featuring questions from our community about treatment,  side effects and what these new advances mean for people living with metastatic breast cancer.We're so happy you joined us! If this conversation resonated with you please share it with someone who might need it. Don't forget to like and subscribe here to follow us on your favorite podcast platform so you never miss an episode. You can find more episodes, resources and ways to get involved on our website Our MBC Life. Have a topic you'd like us to cover? Email us at ourmbclife@sharecancersupport.org. And don't forget to follow us on our socials @ourmbclife. Remember you are not alone.

Hugh continues to broadcast live from the ALEC 2026 Annual Meeting from Orlando Florida, talking with: Texas State Senator Phil King, ALEC Board Member Florida State Representative Demi Busatta, 2026 ALEC National Chair Missouri Senator State Ben Brown Kentucky State Representative Kim Moser Iowa Speaker Pro Tem John Wills Jonathan Williams, ALEC President, Chief Economist California Assemblyman David Tangipa Texas State Representative Caroline Harris Davila Texas State Senator Adam Hinojosa Florida State Representative John Snyder See omnystudio.com/listener for privacy information.

Hugh broadcasts live from the ALEC 2026 Annual Meeting from Orlando Florida, talking with: Lisa Nelson, ALEC CEO TJ Shope, Arizona Senate President Pro Tem, ALEC Board Member Patricia Rucker, West Virginia Senator Assistant Majority Leader, 2025 ALEC National Chair Chris Croft, Kansas House Majority Leader Rob McColley, Ohio Senate President, Lt. Governor candidate Julie Daniels, Oklahoma Senate Majority Floor Leader Michigan House Speaker Matthew Hall, ALEC Board Member Arkansas State Senator Jim Dotson, incoming ALEC chair Jon Brien, Rhode Island Representative, Public Sector Chair of ALEC Process & Procedures Task Force Texas Senator Paul Bettencourt, ALEC State Chair See omnystudio.com/listener for privacy information.